Accéder au contenu
Merck

Semisynthesis and pharmacological investigation of lipo-alkaloids prepared from aconitine.

Fitoterapia (2010-11-16)
Botond Borcsa, Ute Widowitz, Dezso Csupor, Peter Forgo, Rudolf Bauer, Judit Hohmann
RÉSUMÉ

Processed aconite drugs are widely used in Eastern medicine as painkillers and antirheumatic agents. It is known that the traditional processing of aconite drugs increases the amount of lipo-alkaloids. In order to obtain information about the pharmacological potential of these compounds, semisynthesis of 9 aconitine-derived lipo-alkaloids was carried out and their COX-1, COX-2 and LTB(4) formation inhibitory activities were investigated. It was found that compounds esterified with unsaturated fatty acids demonstrated significant COX-2 inhibitory effects, while in the COX-1 assay only 14-benzoylaconine-8-O-eicosapentaenoate exerted remarkable activity. The inhibition of LTB(4) formation was pronounced in cases of long chain fatty acid derivatives.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Supelco
Sephadex® LH-20
Sigma-Aldrich
Aconitine, ≥95% (HPLC), crystalline
Supelco
Acide cis-5,8,11,14,17-eicosapentaénoïque, analytical standard
Supelco
Acide linolénique, analytical standard